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In Vitro Can Be Achieved by Inhibiting
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Objective: Experimental wounding of articular cartilage results in cell death at the lesion edge. The objective of
this study was to investigate whether inhibition of this cell death results in enhanced integrative cartilage repair.
Methods: Bovine articular cartilage discs (6mm) were incubated in media containing inhibitors of necrosis
(Necrostatin-1, Nec-1) or apoptosis (Z-VAD-FMK, ZVF) before cutting a 3mm inner core. This core was left in
situ to create disc=ring composites, cultured for up to 6 weeks with the inhibitors, and analyzed for cell death,
sulfated glycosaminoglycan release, and tissue integration.
Results: Creating the disc=ring composites resulted in a significant increase in necrosis. ZVF significantly re-
duced necrosis and apoptosis at the wound edge. Nec-1 reduced necrosis. Both inhibitors reduced the level of
wound-induced sulfated glycosaminoglycan loss. Toluidine blue staining and electron microscopy of cartilage
revealed significant integration of the wound edges in disc=ring composites treated with ZVF. Nec-1 improved
integration, but to a lesser extent. Push-out testing revealed that ZVF increased adhesive strength compared to
control composites.
Conclusions: This study shows that treatment of articular cartilage with cell death inhibitors during wound
repair increases the number of viable cells at the wound edge, prevents matrix loss, and results in a significant
improvement in cartilage–cartilage integration.
Introduction
Articular cartilage has a low intrinsic capacity forrepair1 with the repair response being impeded by a
lack of integration of the repair tissue with the surrounding
native cartilage. It is well established that wounding of ar-
ticular cartilage leads to apoptotic and necrotic cell death at
the lesion edge2–7; thus, cartilage tissue integration is likely
impaired by a lack of live or viable cells at the interface
region that are capable of producing a functional repair
tissue.8,9 In addition, this is hindered by the inherent limited
ability of chondrocytes to migrate through the extracellular
matrix toward the acellular interface region.9 Because sur-
gical repair of cartilage lesions often requires debridement
and=or reshaping of cartilage, associated chondrocyte death
at the wound edges will be an inevitable problem. Histori-
cally, it has been reported that there is a distinct lack of
integration of repair tissue with the surrounding host carti-
lage, with formation of chondrocyte clusters adjacent to
zones of cartilage necrosis.10 Reindal et al. found that if bo-
vine articular cartilage explants were cultured in partial ap-
position, an increase in adhesive strength was observed and
that this was dependent on the presence of viable chon-
drocytes, and thus active cellular metabolism.11
Therefore, it is generally accepted that increasing the
number of viable chondrocytes at the wound edge will
promote tissue integration.4,8,9,11–13 Indeed, a number of
studies have shown that enzymatic treatment increases cell
density at the wound edges of cartilage explants and en-
hances integrative repair.9,12,13 Interestingly, recent studies
have shown that short-term intra-articular administration of
a potent caspase inhibitor (Z-VAD-FMK, ZVF) results in a
decrease in chondrocyte apoptosis and subsequently less
cartilage degeneration after experimental osteochondral in-
jury in rabbits.14 Further, the use of apoptosis inhibitors
in vivo reduced the number of cells undergoing apoptosis
in cartilage that had been prepared for surgery, leading to
the conclusions that cell death inhibitors could improve the
results of cartilage repair surgery.15 In the light of these
findings, we hypothesized that inhibition of the cell death
1Connective Tissue Biology Laboratories, School of Biosciences, Cardiff University, Cardiff, Wales, United Kingdom.
2School of Optometry & Visual Sciences, Cardiff University, Cardiff, Wales, United Kingdom.
3Smith & Nephew Research Centre, Heslington, York, United Kingdom.
TISSUE ENGINEERING: Part A
Volume 15, Number 7, 2009
ª Mary Ann Liebert, Inc.
DOI: 10.1089=ten.tea.2008.0361
1739
that occurs as a response to wounding of articular cartilage
will result in enhanced cartilage integrative repair.
Materials and Methods
Materials
All chemicals were from Sigma (Poole, United Kingdom)
unless otherwise stated, and were of analytical grade or
above. Culture medium consisted of Dulbecco’s modified
Eagle’s medium (1:1 mixture of DMEM-Glutamax-I and
Hams F12 media) containing 10mM HEPES pH 7.4,
100U=mL penicillin, 100 mg=mL streptomycin, and 50mg=mL
ascorbate-2-phosphate, and supplemented with 1 insulin-
transferrin-sodium selenite (Invitrogen, Paisley, United King-
dom). Insulin-transferrin-sodium selenite supplementation
enables chondrocytes to maintain metabolism in serum-free
conditions without loss of their normal phenotype as well as
preventing activation of stress signaling pathways that occurs
on the withdrawal of serum from culture media.16
Disc=ring composite preparation and culture
Articular cartilage from the metacarpophalangeal joint of
immature bovine steers, in the form of circular explants, was
used to simulate cartilage–cartilage integration in this study.
For each experiment, cartilage was taken from a minimum of
four legs and randomly assigned to a treatment group. Full-
depth cartilage discs (mean depth 2.3mm 0.4mm) were cut
using a 6-mm-diameter biopsy punch (Steifel, Maidenhead,
United Kingdom), removed from the joint, and cultured for
48h in culturemedia at 378C in a humidified atmosphere of 5%
CO2–95% air to establish baseline conditions. After this pre-
treatment period, the 6mm cartilage discs were preincubated
for 3h inmedia containing inhibitors of cell death. Necrostatin-
1 (Nec-1; 30mM; Biomol, Exeter, United Kingdom) was chosen
as an inhibitor of necroptosis a necrosis-like cell death path-
way. This mechanism of cell death is triggered by the same
stimuli that activates apoptosis and is programmed to occur as
a backup mechanism to eliminate damaged cells when apo-
ptosis cannot occur.17 ZVF (20mM) was chosen as a cell per-
meable, irreversible pan-caspase inhibitor. Additional studies
used Z-IETD-FMK (ZIF; 30mM) as a cell permeable, irrevers-
ible caspase-8 inhibitor18 and Z-LEHD-FMK (ZLF; 30mM) as a
cell permeable, irreversible caspase-9 inhibitor.19 Control discs
were incubated in media containing 0.2% (vol=vol) DMSO, the
solvent used to solubilize the inhibitors. At the end of this pe-
riod, a 3mm inner disc was cut using a biopsy punch (Steifel)
and left in situ, thus providing an in vitro model to study the
effect of wound-induced cell death on cartilage–cartilage in-
tegration (Fig. 1). Cartilage disc=ring composites were cultured
for 3 days (gene expression analysis) or 2–6 weeks (cell death=
matrix analysis and mechanical testing) in media containing
the inhibitors (n 3) with cultures being fed with fresh media
and inhibitors every 2–3 days unless stated otherwise. DMSO
(0.2%) was added to cultures not receiving cell death inhibi-
tors. Disc=ring composites (þ= inhibitors) were compared to
6mm cartilage discs.
Analysis of cell death
Determination of necrotic cell death. Primary and sec-
ondary necrotic cell death was assessed using the CytoTox
96 assay according to manufacturer’s instructions (Prome-
ga, Southampton, United Kingdom). This assay quantita-
tively measures lactate dehydrogenase (LDH) present in the
culture media that has been released upon natural lysis of
cells during the culture period.20 Differences in the release of
LDH associated with culture treatment were expressed as
absorbance units.
Determination of apoptotic cell death. To assess the ex-
tent of apoptotic cell death, cartilage was removed from the
medium, washed in phosphate-buffered saline (PBS), and
fixed in 70% (vol=vol) ethanol for 12h at 48C. Disc=ring
composites were processed by wax embedding and cut into
8mm sections. Sections were de-waxed, rehydrated, and ana-
lyzed using the fluorescent version of the FragEL DNA
Fragmentation Detection Kit according to manufacturer’s in-
FIG. 1. Disc=ring model to study cartilage–cartilage inte-
gration. (A) Full-depth articular cartilage discs (6mm) were
taken from the metacarpophalangeal joint of 7-day-old bo-
vine calves, washed in medium, and cultured for 48 h at
378C. After 48 h, discs were incubated for 3 h in media with
and without (þ=) inhibitors of cell death. At the end of this
period, a 3mm inner disc was cut and left in situ, thereby
creating disc=ring composites to study cartilage–cartilage
integration. Composites were cultured for up to 6 weeks
in media þ= inhibitors (n 3 per treatment) with cultures
being fed with fresh inhibitors every 2–3 days. (B) Descrip-
tion of treatment groups used in the study.
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structions (Calbiochem, Nottingham, United Kingdom). This
assay is a nonisotopic system for fluorescein labeling of DNA
breaks in apoptotic nuclei. The total cell population can be
visualized using a DAPI filter, thus allowing the percentage of
apoptotic cells to be calculated. Detection and analysis of la-
beling was by fluorescence microscopy (Olympus).
Analysis of proteoglycan release
The total amount of sulfated glycosaminoglycan (sGAG)
released into the culture medium over 2 weeks was measured
using a modification of the 1,9-dimethylmethylene blue
dye binding (DMMB) assay using chondroitin-4-sulfate-C
from shark cartilage as a standard.21 Differences in the release
of sGAG associated with culture treatment were expressed as
mg of GAG per mL of media.
Histological and immunohistological analysis
of cartilage composites
Sections (see the section Determination of apoptotic cell
death) were de-waxed, rehydrated, and stained with a 0.1%
aqueous solution of toluidine blue to show the distribution of
glycosaminoglycans in the cartilage. Sections (two per zone
for each treatment) were chosen randomly from within the
superficial, mid, and deep zone and scored for the amount of
integration. This was assessed under high magnification, as
new tissue growth between the two cut surfaces, and ex-
pressed as a percentage of the total cut surface. Cartilage–
cartilage integration was also assessed by immunohisto-
chemistry. Briefly, sections were de-waxed, rehydrated, and
washed extensively in PBS before blocking in 2% (vol=vol)
normal goat serum for 1 h at room temperature. Sections
were incubated overnight at 48C with a mouse monoclonal
antibody to type II collagen (CIICI, Hybridoma bank, NIH)
diluted in PBS (1:5). Sections were subsequently washed in
PBS before being incubated for 1 h at room temperature with
a FITC-conjugated anti-mouse secondary antibody diluted
1:100 in PBS. After extensive washing in PBS, sections were
mounted in Vectashield Mounting Medium containing
DAPI (1.5 mg=mL) to counterstain DNA (Vector Labs,
Peterborough, United Kingdom). Labeling was observed
using an Olympus BX61 fluorescence microscope.
Scanning and transmission electron microscopy
For scanning electron microscopy (SEM), cartilage was
removed from the medium, washed in PBS, fixed in 2.5%
glutaraldehyde for 3 h at 48C, and postfixed in 2% osmium
tetroxide secondary fixative for 2 h at room temperature. The
samples were fully dehydrated using 70–100% graded eth-
anol, critically point dried, and sputter coated under vacuum
in gold. Samples were examined using the Phillips XL-
20 scanning electron microscope. For transmission electron
microscopy (TEM), cartilage was processed postfixing for
ultrastructural analysis22 and examined using the Philips 208
TEM at 80 kV.
Quantitative PCR analysis of gene expression
Cartilage explants were cultured for 3 days and snap frozen
in liquid nitrogen before the addition of 1mL of Trizol
(Invitrogen). Cartilage was powdered in a dismembrator
(B. Braun Biotech, Allentown, PA), and total RNA extracted
according to the manufacturer’s instructions (Invitrogen) but
with the following exceptions. After the addition of the chlo-
roform, the whole RNA extraction mix was transferred to a
tube containing Heavy Phase-lock Gel (Eppendorf, Fisher
Scientific, Loughborough, United Kingdom) and centrifuged
at 13,000g for 2min at 48C. The upper aqueous layer was re-
moved to a new Eppendorf tube, an equal volume of iso-
propanol added, and the RNA left to precipitate overnight
at 208C. At the end of the extraction protocol, the RNA
was DNase treated to remove genomic DNA (Ambion, Hun-
tingdon, United Kingdom) and resuspended in 50mL RNase-
free water. cDNA was generated in a single 20mL reaction
from 11mL RNA sample using 250ng random hexamers
(0.5mg=mL; Promega) and Superscript III reverse transcrip-
tase (200units; Invitrogen).
Expression of type II collagenwasmeasured by SYBR green
quantitative PCR (qPCR) using the MX3000P qPCR system
according to manufacturer’s instructions (Stratagene) with
200nM forward (50-AACGGTGGCTTCCACTTC-30) and re-
verse (50-GCAGGAAGGTCATCTGGA-30) primers.23 Fold
change relative to 6mm discs were calculated using the DDCT
method with 18s ribosomal RNA (50-GCAATTATTCCC
CATGAACG-30 and 50-GGCCTCACTAAACCATCCAA-30)
as the reference gene.24 All primers were purchased from
Eurofins MWG Operon (London, United Kingdom).
Western blotting
Disc=ring cartilage composites were snap frozen in liq-
uid nitrogen before being powdered in a dismembrator (B.
Braun Biotech Int.). Proteoglycans were extracted with 4M
guanidine-HCl for 24 h at 48C, and samples centrifuged at
30,000 g for 15min at 48C. Pellets were washed with 0.5M
acetic acid before digestion with pepsin (1:10 wet weight) in
0.5M acetic acid for 24 h at 48C. Samples were centrifuged at
30,000 g for 15min at 48C, and the supernatant containing
pepsin-soluble collagen was analyzed by hydroxyproline
assay25 before Western blot analysis.
An equal amount of collagen from control (untreated) and
ZVF-treated samples were diluted 1:1 in sample buffer (0.12M
Tris=HCl [pH 6.8], containing 4% [w=v] SDS, 20% [v=v] glyc-
erol, and 0.01% [w=v] bromophenol blue), reduced (2.5%
vol=vol b-mercaptoethanol), and resolved on 7.5% (wt=vol)
SDS-polyacrylamide gels. For each analysis, control and ZVF-
treated samples were run on the same gel for direct compari-
son. Protein was transferred to PVDFmembranes (Immobilon;
Millipore, Watford, United Kingdom) and blocked for 1 h at
room temperature in blocking buffer (Tris buffered saline with
Tween 20 [TBST]; 0.15M NaCl, 0.05M Tris=HCl pH 8.0, 3%
[wt=vol] skimmed milk powder, and 0.05% [vol=vol] Tween
20). After washing (TBST), membranes were incubated for 2 h
at room temperature with a monoclonal antibody to type II
collagen (1:5 dilution of antibody AVT6E316) diluted in TBST.
Membranes were washed and incubated for 1 h at room tem-
perature in appropriate horseradish peroxidase–conjugated
IgG. Bands were detected using enhanced chemiluminescence
reagents using multiple sheets of Hyperfilm-ECL (GE Health-
care, Little Chalfont, United Kingdom), and various exposure
times to ensure samples were within the linear range.26 Blots
were scanned (Umax Magic scan) and analyzed by densitom-
etry (NIH Image).
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Mechanical testing
Disc=ring composites were treated with ZVF for 4-days
and cultured for a total of 6 weeks. Adhesive properties of
the disc=ring interface after 6 weeks in culture were assessed
using a push-out test. Thickness of the sample was measured
using calipers. A custom-made mechanical testing device in
which a push-out rod displaced the disc from the ring (at a
rate of 11018N=mm2=s) was used to test the adhesive
strength with a Lloyd LRX material testing machine (Lloyds
Instruments, Hants, UK). A computer-activated micro-step-
per controlled the displacement of the push-out rod, while a
load cell (100N) coupled to the rod measured the push-out
force. The adhesive strength was calculated from the maxi-
mum force measured at failure per unit of interfacial area.
Statistical analysis
Where appropriate, data are presented as mean SEM
(n 3 replicates per treatment) and tested for normality and
equal variances before parametric analysis (Minitab).
Results
Effect of Nec-1 and ZVF on chondrocyte death
Analysis of necrotic cell death. Significant differences
were observed in the extent of LDH release into the media
during the first 48h of culture representing primary and sec-
ondary necrosis (one-way ANOVA, p< 0.001; Fig. 2A). Es-
tablishing the disc=ring composites resulted in a significant
increase in LDH release (Fisher’s post hoc test; p< 0.001).
Treatment of disc=ring composites with ZVF significantly re-
duced the extent of necrosis that occurred within 48h of
wounding (Fisher’s post hoc test; p< 0.001) so that necrosis
levels were not significantly different to levels in the 6mm
discs. Nec-1 reduced LDH release when compared to control
(untreated) disc=ring composites (Fisher’s post hoc test;
p< 0.01), but levels were still significantly higher than the
6mm discs (Fisher’s post hoc test; p< 0.01). Similar trends were
observed over the first 7 days in culture after which negligible
LDH release occurred in all cultures (data not shown).
Analysis of apoptotic cell death. The effect of wounding
on apoptosis and the efficacy of the pan-caspase inhibitor,
ZVF, in inhibiting apoptosis was assessed using the Fra-
gEL DNA Fragmentation Detection Kit (Calbiochem).
After 2 weeks of culture, disc=ring composites were sec-
tioned and analyzed for the presence of apoptotic nuclei (Fig.
2B). In the superficial zone of control (untreated) disc=ring
composites, extensive numbers of apoptotic nuclei were de-
tected extending several micrometers from the wound edge
of both the inner disc and outer ring. In the mid zone, apo-
ptotic nuclei were present but were more restricted to the
wound edge. Treatment with ZVF markedly reduced the
number of apoptotic nuclei detected in the superficial and
mid zones. Equivalent numbers of apoptotic nuclei were
detected in the deep zone of control and ZVF-treated com-
posites (sections not shown).
Effect of Nec-1 and ZVF on the release
of proteoglycans
Using the DMMB assay, significant differences were ob-
served in the total amount of sGAG released into the media
over 2 weeks (one-way ANOVA, p< 0.05; Fig. 2C). The level
of sGAG released into the media was higher in disc=ring
cultures compared to the 6mm discs (Fisher’s post hoc test;
p< 0.05). Treatment of disc=ring composites with either of
the inhibitors resulted in levels of sGAG in the media that
were comparable to the 6mm discs.
Effect of Nec-1 and ZVF
on cartilage–cartilage integration
Disc=ring composites were cultured for 2 weeks in the
presence or absence of cell death inhibitors, fixed, embedded
in wax, and 8mm sections assessed for integration by im-
munolabeling for type II collagen (Fig. 3A). Disc=ring com-
posites that had not been treated with cell death inhibitors
consistently showed no signs of integration, whereas en-
hanced integration was observed in cartilage composites
treated with ZVF or Nec-1. The extent of integration was
further analyzed by staining sections with toluidine blue for
the presence of proteoglycans (Fig. 3B, C). Little or no inte-
gration of wound edges was observed throughout the full
depth of control (untreated) disc=ring composites (1.0–5.5%
of the total wound edge). In contrast, treatment with ZVF
resulted in enhanced integration around the entire cut sur-
face, throughout the full depth of the tissue (61.0–71.0% of
the total wound edge). When ZVF-treated composites were
analyzed under higher power (Fig. 3C), areas of complete
integration were seen as well as areas of newly forming tis-
sue. Nec-1 treatment improved integration compared to
control disc=ring composites but not around the entire cut
surface and not throughout the full depth (7.0–34.5% of the
total wound edge). Because the use of ZVF to inhibit cell
death produced more complete areas of integration and re-
duced LDH and sGAG release, apoptotic death pathways
were targeted for further investigation.
Targeting of specific caspases
To determine whether specific caspases could be targeted to
improve integration, disc=ring composites cultured in the
presence of the pan-caspase inhibitor, ZVF, were compared to
those treated with the caspase-8 inhibitor, ZIF, or the caspase-
9 inhibitor, ZLF. SEM was used to assess the extent of inte-
gration at the end of 2 weeks in culture (Fig. 4A). Control
composites showed no signs of integration, whereas almost
complete integration of the wound edges was observed in
composites treated with the pan-caspase inhibitor, ZVF. Dis-
c=ring composites treated with either ZIF or ZLF showed
some areas of integration but not to the same extent as ZVF.
To establish whether integration was occurring through-
out the full depth of the cartilage, sections were taken from
the superficial, mid, and deep zones and stained with tolu-
idine blue for the presence of proteoglycans (Fig. 4B). In the
superficial zone of control composites, there were some areas
where new proteoglycan was forming but also extensive
areas of little or no new tissue formation. There were no
areas of complete integration. Within the mid zone there
were areas of no tissue formation as well as areas where
complete wound closure had occurred. Treatment with the
caspase-9 inhibitor, ZLF, improved integration in the su-
perficial zone and resulted in areas of complete wound clo-
sure, partial infilling of the wound gap, as well as areas of
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FIG. 2. Analysis of cell death and
sGAG loss. (A) Primary and secondary
necrotic cell death occurring in cartilage
composites treated with various cell
death inhibitors in the 48 h postwound-
ing was assessed by measuring LDH
release into the culture media (one-way
ANOVA and Fisher’s post hoc test;
**p< 0.01 and ***p< 0.001; n¼ 3 com-
posites per treatment). (B) The effect of
wounding on apoptosis and the efficacy
of the pan-caspase inhibitor, ZVF, in in-
hibiting apoptosis was assessed using
the FragEL DNA Fragmentation De-
tection Kit. Cartilage was cultured for 2
weeks, and sections were analyzed for
the presence of apoptotic nuclei. Super-
ficial and mid zone sections are shown.
Wound edges (white lines) and inner
(3mm) disc (*) are indicated. The
number of apoptotic nuclei in the su-
perficial (SZ), mid, and deep zones were
counted, plotted graphically as a per-
centage of the total number of cells, and
compared to 6mm discs. Scale
bars¼ 100 mm. (C) The amount of sGAG
lost into the media over the 2-week cul-
ture period was assessed using the
DMMB assay. Cartilage composites were
cultured in the presence or absence of
cell death inhibitors for 2 weeks, and
media collected every 2–3 days. Data are
plotted as total sGAG SEM (mg=mL)
and analyzed by one-way ANOVA and
Fisher’s post hoc test (*p< 0.05; n¼ 3per
treatment). Color images available
online at www.liebertonline.com=ten.
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FIG. 3. Histological and
immunohistological analysis of
cartilage–cartilage integration.
Disc=ring composites were cultured
for 2 weeks in the presence or absence
of cell death inhibitors, fixed, em-
bedded in wax, and 8 mm sections
assessed for integration by immuno-
histochemistry (A) and histology
(B, C). (A) Sections were stained for
the presence of type II collagen using
a monoclonal antibody to the triple
helical region of the molecule (CIICI)
followed by FITC–conjugated sec-
ondary. Sections were mounted
in Vectashield containing DAPI to
counterstain DNA. Arrows indicate
areas of integrative repair. Scale
bar¼ 100 mm. (B) Sections were
stained with toluidine blue to detect
proteoglycans. Sections shown are
representative of two sections chosen
randomly from the superficial (SZ),
mid, and deep zones. The amount of
integration, assessed under high
magnification as new tissue growth
between the two cut surfaces, is
shown below each panel expressed as
a percentage of the total cut surface.
Scale bar¼ 1mm. (C) Detailed view
of the interface region from ZVF-
treated and Nec-1–treated cartilage.
Arrows indicate wound edge. Scale
bar¼ 100 mm. Color images available
online at www.liebertonline.com=ten.
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little integration. Within the mid zone, there were areas of
wound closure and complete tissue integration. Results were
similar in composites treated with the caspase-8 inhibitor,
ZIF (data not shown). In disc=ring composites treated with
the pan-caspase inhibitor, ZVF, integration was observed
within the superficial zone, and there were fewer areas of
partial proteoglycan infilling and more areas where complete
wound closure was apparent. Integration was observed be-
tween large areas of the wound edge within the mid zone.
Analysis of extracellular matrix expression
and deposition
Quantitative PCR was performed to determine whether
inhibiting wound-induced apoptosis with ZVF altered type
II collagen mRNA expression (Fig. 5A). Within 3 days of
treatment with ZVF, disc=ring composites exhibited a sig-
nificant, 9.6-fold increase in the expression of type II collagen
mRNA compared to control (untreated) disc=ring compos-
ites (Student’s two-sample t-test, p< 0.001; Fig. 5A) and a 5.6-
fold increase over the 6mm discs (Student’s two-sample
t-test, p< 0.05; Fig. 5A).
In addition, after 3 weeks in culture, pepsin-soluble col-
lagen was extracted from control and ZVF-treated disc=ring
composites, and an equivalent amount of total collagen an-
alyzed for type II collagen quantification by Western blotting
(Fig. 5B). After 3 weeks, there was no significant difference in
the amount of type II collagen protein present in the total
disc=ring composite (Student’s two-sample t-test, p¼ 0.100,
after Johnson’s transformation of data).
FIG. 4. Analysis of integration after targeted caspase inhibition. To determine whether specific caspases could be targeted to
improve integration, disc=ring composites were cultured in the presence of the pan-caspase inhibitor, ZVF, the caspase-8
inhibitor, ZIF, or the caspase-9 inhibitor, ZLF. At the end of 2 weeks, cartilage was (A) processed and examined using SEM
(top panels,50 magnification; bottom panels,100 magnification) or (B) fixed, embedded in wax, and 8 mm sections stained
with toluidine blue to detect proteoglycans. Sections taken from the superficial and mid zones of cartilage left untreated (top
panels), treated with ZLF (mid panels), and treated with ZVF (bottom panels) are shown. Scale bar¼ 100 mm. Color images
available online at www.liebertonline.com=ten.
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TEM was used to observe the ultra-structure of the matrix
forming between the wound edges of ZVF-treated disc=ring
composites (Fig. 5C). After 2 weeks, a basket-like weave of
newly formed collagen fibrils was observed between the
wound edges of ZVF-treated cartilage. In some areas, a
narrower wound gap was observed.
Mechanical testing
The adhesive strength of the interface material formed
after 6 weeks in culture was tested by push-out test (Fig. 6A).
A significant difference was detected in the stress-to-failure
in ZVF-treated disc=ring composites over control composites
(0.333 0.041N=mm2 vs. 0.065 0.043N=mm2) (Student’s
two-sample t-test, p¼ 0.003; Fig. 6B).
Discussion
This study utilized a bovine articular cartilage disc=ring
composite model to assess the effects of inhibiting cell death
on cartilage-integrated repair. Bovine cartilage has been
widely used to investigate cartilage integration and produces
FIG. 5. Analysis of type II collagen expression and deposition. (A) RNA from 6mm discs (n¼ 4), and untreated (n¼ 6) or
ZVF-treated (n¼ 5) disc=ring composites was analyzed by quantitative PCR to determine the relative expression of type II
collagen. Data are presented as fold change relative to 6mm discs calculated using the DDCT method with 18s ribosomal
RNA as the reference gene and plotted as mean SEM (Student’s two-sample t-test, ***p< 0.001 and **p< 0.01). (B) Pepsin-
soluble collagen was extracted from disc=ring composites cultured for 3 weeks and an equivalent amount of total collagen
analyzed for type II collagen by Western blotting. Control and ZVF-treated samples were run on the same gel to allow direct
comparisons to be made. Levels of type II collagen are plotted as mean densitometric units SEM (n¼ 4 per treatment;
Student’s two-sample t-test, p¼ 0.100). (C) At the end of 2 weeks in culture, cartilage composites were processed for
dedicated ultra-structural analysis by TEM. Collagen fibrils were observed between the wound edges of ZVF-treated com-
posites (magnification,8000). Narrower wound gaps were observed in some areas (magnification,10,000). Arrows indicate
the wound edges.
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a reproducible response upon surgical wounding indicative
of early trauma in the joint, thus providing a model system
to study the basic mechanisms behind cartilage repair.12,27,28
Given that increasing cell viability at the wound edge aids in
the integrative process,9 we investigated whether inhibition
of cell death pathways results in enhanced, integrated car-
tilage repair. Necrotic and apoptotic cell death pathways
were chosen as targets because these have both been shown
to be induced by wounding in articular cartilage.2 An in-
crease in both necrotic and apoptotic cell death was observed
after establishment of the disc=ring composites. This is in
agreement with recent results showing that experimental
wounding of articular cartilage leads to cell death at the le-
sion edge2–4 and thus confirms that our model mimics es-
tablished models of cartilage wounding with respect to the
cell death response. The loss of cell viability that was ob-
served after establishment of the model was significantly
reduced by preincubating the cartilage, before cutting the
3mm disc, with inhibitors of cell death pathways—in par-
ticular, ZVF. The fact that ZVF, an apoptosis inhibitor, re-
duced LDH release, a marker of necrosis, suggests a
secondary necrotic response after an initial apoptotic stimu-
lus. This phenomenon may occur in cartilage where in the
absence of phagocytosis to remove the dead cells, membrane
integrity is lost and the cell disintegrates.29 In addition to
increasing cell death, wounding also increased proteoglycan
loss from the cartilage composites that over the culture pe-
riod could be reduced by incubating the composites with the
cell death inhibitors. These data suggest that inhibiting the
wound-induced death prevents matrix loss and may con-
tribute to improved integration. In addition, the expression
of mRNA for type II collagen, the matrix component most
important for mechanical integrity of articular cartilage, was
enhanced almost 10-fold by inhibiting cell death. Analysis of
type II protein levels showed no significant enhancement
over a 3-week period although levels detected in the whole
explant were 60% higher. This suggests that either with more
time or by sampling only the wound edges, the protein levels
may better correlate with the mRNA expression data
showing significantly increased type II collagen deposition
essential for an effective repair.
In all cases, inhibition of cell death improved cartilage
integrative repair with the percentage of contact between
wound edges (new tissue formed) being substantially more
with each of the inhibitors than that observed in untreated
composites. Inhibition of cell death with ZVF, however,
consistently produced a more superior integration in that
there was a higher percentage of contact around the whole of
the wound edge in addition to better integration throughout
the full depth of the cartilage. ZVF markedly reduced the
number of apoptotic nuclei detected that appeared to coin-
cide with areas of enhanced integration (see Fig. 2B). Inter-
estingly, where there were higher levels of apoptotic nuclei,
integration appeared impeded, supporting a direct relation-
ship between the number of viable cells and successful
cartilage–cartilage integration.
Because the use of an apoptotic cell death inhibitor ap-
peared to enhance integration around the wound edge and
throughout the depth of the cartilage, over that achieved
with inhibition of necrotic-like death pathways, two specific
caspases were targeted in an attempt to delineate the apo-
ptosis pathway involved. The caspase-8 inhibitor, ZIF, was
chosen as an inhibitor of the death receptor–induced apo-
ptosis pathway, and the caspase-9 inhibitor, ZLF, as an in-
hibitor of the mitochondrial apoptosis pathway. SEM
indicated that while all three caspase inhibitors improved
integration compared to that observed in untreated, control
composites, the extent of integration was better in ZVF-
treated cartilage (ZVF>ZIF>ZLF). The observation that ZLF
was less successful in enhancing integration may be due to
the fact that this inhibitor induced more necrosis and sGAG
loss (data not shown). This finding was supported by his-
tology. Interestingly, toluidine blue staining indicated that
while there was evidence of new GAG synthesis between the
wound edges of control cartilage, total integration within the
superficial zone was impeded. This was in contrast to com-
posites treated with the caspase inhibitors that had areas of
complete integration within this zone. This is in keeping
with the finding that the majority of wound-induced apo-
ptosis occurs within this zone, which is consistent with pre-
viously published data.2,7 Thus, inhibiting this death would
FIG. 6. Mechanical testing of newly formed tissue at the
interface. (A) Schematic representation of the custom-built
push-out rig. A computer-activated micro-stepper controls
the displacement of the push-out rod (11018N=mm2=s),
while a load cell (100N) coupled to the rod measured the
push-out force. (B) After 6 weeks in culture, the adhesive
strength of the newly formed interface material was calcu-
lated from the maximum force measured at failure (N) per
unit of interfacial area (mm2). Data are presented as mean
 SEM of control (n¼ 4) and ZVF-treated (n¼ 5) disc=ring
composites and analyzed by Student’s two-sample t-test
(**p¼ 0.003).
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maintain viable cells close to the wound edge to aid inte-
gration, again confirming the close correlation between the
number of viable cells and successful integration. The rela-
tive effectiveness of the three inhibitors suggests that more
than one apoptotic mechanism is activated by wounding,
hence the pan-caspase inhibitor, ZVF, being by far the most
efficacious in enhancing the repair process.
Ultra-structural analysis of the interfacial material to in-
vestigate the integrative repair response in more detail re-
vealed the presence of a basket-like weave of collagen fibrils
between the wound edges of ZVF-treated cartilage. The size
of the wound gap was variable, with some areas being
narrower than others. This observation is consistent with
the findings of Moretti et al., who found variable wound gap
widths but showed that more mature fibrils were pres-
ent only within the narrowest of interfacial regions.27 As a
functional test of the integration, push-out testing was used
to determine the adhesive strength of the newly formed tis-
sue at the wound edge. After 6 weeks in culture, ZVF sig-
nificantly enhanced the adhesive strength. Overall, the
adhesive strength of the newly formed material was low. The
presence of more immature fibrils between the wound edges,
not extensively crossing into the surrounding cartilage ma-
trix, may provide an explanation for this. Moretti et al. also
showed the presence of small immature collagen fibrils that
were not integrated with the adjacent explant matrix in their
disc=ring composites and hypothesized that this contributed
to the relatively low adhesive strength of the composites.27
Previous studies have shown that cartilage integration is
mediated by collagen deposition30 and that the deposition of
collagen fibrils between the wound edges in ZVF-treated
composites would support this. In addition, we hypothesize
that this collagen is type II collagen because its expression
is increased in disc=ring composites treated with ZVF. An
extended culture period will enable the newly formed fi-
brils to mature by aggregating into larger, banded fibrils
and undergoing crosslinking comparable to the endogenous
tissue.
This study has shown, for the first time, that by using
broad spectrum inhibitors of apoptotic cell death, the extent
of cell death at the wound edge can be significantly reduced
resulting in enhanced tissue integration in immature tissue
in vitro. Further studies are, therefore, clearly warranted to
study the use of caspase inhibitors in a wider setting par-
ticularly in older tissue as well as in vivo because they may
be a good candidate to promote cartilage integration, a pro-
cess that remains problematical in clinical cartilage repair
strategies.
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